Latanoprost detailed information

Jump to navigation Jump to search
Latanoprost detailed information
Clinical data
Routes of
administration
Topical (eye drops)
ATC code
Pharmacokinetic data
Elimination half-life17 minutes
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC26H40O5
Molar mass432.593 g/mol

WikiDoc Resources for Latanoprost detailed information

Articles

Most recent articles on Latanoprost detailed information

Most cited articles on Latanoprost detailed information

Review articles on Latanoprost detailed information

Articles on Latanoprost detailed information in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Latanoprost detailed information

Images of Latanoprost detailed information

Photos of Latanoprost detailed information

Podcasts & MP3s on Latanoprost detailed information

Videos on Latanoprost detailed information

Evidence Based Medicine

Cochrane Collaboration on Latanoprost detailed information

Bandolier on Latanoprost detailed information

TRIP on Latanoprost detailed information

Clinical Trials

Ongoing Trials on Latanoprost detailed information at Clinical Trials.gov

Trial results on Latanoprost detailed information

Clinical Trials on Latanoprost detailed information at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Latanoprost detailed information

NICE Guidance on Latanoprost detailed information

NHS PRODIGY Guidance

FDA on Latanoprost detailed information

CDC on Latanoprost detailed information

Books

Books on Latanoprost detailed information

News

Latanoprost detailed information in the news

Be alerted to news on Latanoprost detailed information

News trends on Latanoprost detailed information

Commentary

Blogs on Latanoprost detailed information

Definitions

Definitions of Latanoprost detailed information

Patient Resources / Community

Patient resources on Latanoprost detailed information

Discussion groups on Latanoprost detailed information

Patient Handouts on Latanoprost detailed information

Directions to Hospitals Treating Latanoprost detailed information

Risk calculators and risk factors for Latanoprost detailed information

Healthcare Provider Resources

Symptoms of Latanoprost detailed information

Causes & Risk Factors for Latanoprost detailed information

Diagnostic studies for Latanoprost detailed information

Treatment of Latanoprost detailed information

Continuing Medical Education (CME)

CME Programs on Latanoprost detailed information

International

Latanoprost detailed information en Espanol

Latanoprost detailed information en Francais

Business

Latanoprost detailed information in the Marketplace

Patents on Latanoprost detailed information

Experimental / Informatics

List of terms related to Latanoprost detailed information


Latanoprost (pronounced la-TA-noe-prost) ophthalmic solution is a topical medication used for controlling the progression of glaucoma or ocular hypertension, by reducing intraocular pressure. It is a prostaglandin analogue that works by increasing the outflow of aqueous fluid from the eyes.

It is also known by the brand name of Xalatan manufactured by Pfizer.

Side effects

Possible side effects:

  • May cause reddening of the eyes (hyperemia)
  • May cause blurred vision;
  • May cause eyelid redness;
  • May permanently darken eyelashes;
  • May cause eye discomfort;
  • May eventually cause permanent darkening of the iris to brown (heterochromia);
  • May cause a temporary burning sensation during use.
  • May cause thickening of the eyelashes.
  • Rarely, herpes simplex keratitis.

External links

  • Xalatan (manufacturer's website)
  • Hara T (2001). "Increased iris pigmentation after use of latanoprost in Japanese brown eyes". Nippon Ganka Gakkai Zasshi. 105 (5): 314–21. PMID 11406947.


Template:Antiglaucoma preparations and miotics Template:Prostaglandins

Template:WH Template:WS